[go: up one dir, main page]

MX2021001118A - Composiciones que comprenden fibras obtenidas electrohidrodinamicamente para la administracion de dosificaciones especificas de una sustancia activa a piel o mucosa. - Google Patents

Composiciones que comprenden fibras obtenidas electrohidrodinamicamente para la administracion de dosificaciones especificas de una sustancia activa a piel o mucosa.

Info

Publication number
MX2021001118A
MX2021001118A MX2021001118A MX2021001118A MX2021001118A MX 2021001118 A MX2021001118 A MX 2021001118A MX 2021001118 A MX2021001118 A MX 2021001118A MX 2021001118 A MX2021001118 A MX 2021001118A MX 2021001118 A MX2021001118 A MX 2021001118A
Authority
MX
Mexico
Prior art keywords
mucosa
administration
skin
compositions
active substance
Prior art date
Application number
MX2021001118A
Other languages
English (en)
Inventor
Jens Hansen
Lars Hellerung Christiansen
Original Assignee
Afyx Therapeutics As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Afyx Therapeutics As filed Critical Afyx Therapeutics As
Publication of MX2021001118A publication Critical patent/MX2021001118A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D1/00—Treatment of filament-forming or like material
    • D01D1/02—Preparation of spinning solutions
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00—General methods for the manufacture of artificial filaments or the like
    • D01F1/02—Addition of substances to the spinning solution or to the melt
    • D01F1/10—Other agents for modifying properties
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/44—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/44—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds
    • D01F6/52—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds of polymers of unsaturated carboxylic acids or unsaturated esters
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/44—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds
    • D01F6/56—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds of polymers of cyclic compounds with one carbon-to-carbon double bond in the side chain
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/88—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds
    • D—TEXTILES; PAPER
    • D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
    • D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • D—TEXTILES; PAPER
    • D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2201/00—Cellulose-based fibres, e.g. vegetable fibres
    • D10B2201/20—Cellulose-derived artificial fibres
    • D10B2201/28—Cellulose esters or ethers, e.g. cellulose acetate
    • D10B2201/30—Ethers, e.g. CMC
    • D—TEXTILES; PAPER
    • D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2321/00—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D10B2321/08—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds polymers of unsaturated carboxylic acids or unsaturated organic esters, e.g. polyacrylic esters, polyvinyl acetate
    • D—TEXTILES; PAPER
    • D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2321/00—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D10B2321/12—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds polymers of cyclic compounds with one carbon-to-carbon double bond in the side chain
    • D—TEXTILES; PAPER
    • D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2331/00—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
    • D10B2331/06—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyethers
    • D—TEXTILES; PAPER
    • D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2509/00—Medical; Hygiene

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Textile Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mechanical Engineering (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a fibras electrohiladas que comprenden i) un polímero hidrófilo que es soluble en un primer solvente, ii) una sustancia bioadhesiva que es ligeramente soluble en el primer solvente, iii) opcionalmente, una sustancia farmacológica.
MX2021001118A 2014-06-10 2016-11-29 Composiciones que comprenden fibras obtenidas electrohidrodinamicamente para la administracion de dosificaciones especificas de una sustancia activa a piel o mucosa. MX2021001118A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201470342 2014-06-10
DKPA201470815 2014-12-22

Publications (1)

Publication Number Publication Date
MX2021001118A true MX2021001118A (es) 2021-07-02

Family

ID=53373453

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016015688A MX2016015688A (es) 2014-06-10 2015-06-09 Composiciones que comprenden fibras obtenidas electrohidrodinamicamente para la administracion de dosificaciones especificas de una sustancia activa a piel o mucosa.
MX2021001118A MX2021001118A (es) 2014-06-10 2016-11-29 Composiciones que comprenden fibras obtenidas electrohidrodinamicamente para la administracion de dosificaciones especificas de una sustancia activa a piel o mucosa.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2016015688A MX2016015688A (es) 2014-06-10 2015-06-09 Composiciones que comprenden fibras obtenidas electrohidrodinamicamente para la administracion de dosificaciones especificas de una sustancia activa a piel o mucosa.

Country Status (17)

Country Link
US (5) US10052291B2 (es)
EP (2) EP3622947B8 (es)
JP (2) JP6591536B2 (es)
KR (2) KR102185355B1 (es)
CN (1) CN107072937A (es)
AU (2) AU2015273608C1 (es)
BR (1) BR112016028961B1 (es)
CA (1) CA2950821C (es)
DK (1) DK3154513T3 (es)
ES (1) ES2763524T3 (es)
IL (3) IL291842A (es)
MX (2) MX2016015688A (es)
MY (1) MY173739A (es)
NZ (2) NZ727975A (es)
RU (2) RU2019121301A (es)
SG (2) SG10201808743VA (es)
WO (1) WO2015189212A1 (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ201124A3 (cs) 2011-01-17 2012-06-13 Elmarco S.R.O. Nosic pro oromukosální, zejména pro sublingvální aplikaci fyziologicky aktivních látek
EP3587573A1 (en) 2011-06-16 2020-01-01 The Regents of The University of California Synthetic gene clusters
US10968446B2 (en) 2012-11-01 2021-04-06 Massachusetts Institute Of Technology Directed evolution of synthetic gene cluster
WO2016079246A1 (en) * 2014-11-20 2016-05-26 Dermtreat Aps Bioadhesive films
MX421690B (es) 2015-07-13 2025-03-14 Pivot Bio Inc Metodos y composiciones para mejorar atributos de plantas
WO2017062412A1 (en) 2015-10-05 2017-04-13 Massachusetts Institute Of Technology Nitrogen fixation using refactored nif clusters
JP6606279B2 (ja) * 2015-11-19 2019-11-13 エーエフワイエックス・セラピューティクス・エー／エス 適用部位における滞留時間が改善された、電気流体力学的に得られた繊維を含む医薬組成物
JP7234116B2 (ja) 2017-01-12 2023-03-07 ピボット バイオ， インコーポレイテッド 植物形質を改善するための方法および組成物
RU2019126497A (ru) * 2017-01-23 2021-02-24 Афикс Терапьютикс А/С Способ получения электроспряденных волокон с высоким содержанием биоадгезивнго вещества
EP3570821B1 (en) * 2017-01-23 2021-07-21 AFYX Therapeutics A/S Method for fabrication of a two-layered product based on electrospun fibres
CN106667913A (zh) * 2017-02-13 2017-05-17 东华大学 一种载药pH敏感自组装脂质体的制备方法
CN107447366A (zh) * 2017-08-03 2017-12-08 东华大学 一种pH敏感载药缓释纳米纤维膜及其制备方法和应用
CN107419432A (zh) * 2017-08-03 2017-12-01 东华大学 一种双敏感载药纳米纤维膜及其制备方法和应用
JP2020536955A (ja) 2017-10-06 2020-12-17 ファウンドリー セラピューティクス， インコーポレイテッド 治療剤の制御放出のための埋込み可能なデポー
AU2018354221B2 (en) 2017-10-25 2025-04-17 Pivot Bio, Inc. Methods and compositions for improving engineered microbes that fix nitrogen
CN111936160B (zh) 2017-10-25 2024-08-13 阿莱罗治疗私人有限公司 通过施用抗原特异性配制品治疗免疫性疾病
CN117757706A (zh) 2017-10-25 2024-03-26 皮沃特生物股份有限公司 靶向改良植物性状的固氮的基因靶标
EP3479693A1 (en) * 2017-11-01 2019-05-08 Everris International B.V. Sulfide containing polyester coatings for agrochemical composition
CN112367980A (zh) 2018-05-12 2021-02-12 铸造疗法股份有限公司 用于控制释放治疗剂的可植入贮库
CN108998847A (zh) * 2018-08-25 2018-12-14 诺斯贝尔化妆品股份有限公司 一种活性纳米包裹体静电纺丝纤维膜布的制备方法
CN112867484A (zh) 2018-08-28 2021-05-28 铸造疗法股份有限公司 聚合物植入物
US20210353532A1 (en) 2018-08-28 2021-11-18 Foundry Therapeutics 1, Inc. Devices, systems, and methods for delivering, positioning, and securing polymer depots in situ
JP7512280B2 (ja) * 2018-12-07 2024-07-08 ピボット バイオ， インコーポレイテッド 窒素固定微生物製品のための改善された安定性を有するポリマー組成物
US12281299B2 (en) 2019-03-19 2025-04-22 Massachusetts Institute Of Technology Control of nitrogen fixation in rhizobia that associate with cereals
WO2020210770A1 (en) 2019-04-11 2020-10-15 Foundry Therapeutics, Inc. Implantable depots for localized, sustained, controlled release of therapeutic agents to treat cancer and related symptoms and conditions
FI20195397A1 (en) * 2019-05-14 2020-11-15 Capsamedix Oy Oral control device for controlled release
CN112107559B (zh) * 2019-06-20 2023-09-08 普济生物科技（台州）有限公司 口腔透粘膜药物剂型
WO2021050532A1 (en) * 2019-09-09 2021-03-18 Afyx Therapeutics A/S Compositions for treating fungal infections
WO2021072113A1 (en) 2019-10-08 2021-04-15 Afyx Therapeutics A/S Compositions for the delivery of proteins
CN113597303B (zh) * 2019-12-20 2022-11-18 罗曼治疗系统股份公司 含有阿戈美拉汀的经粘膜治疗系统
JP2023518675A (ja) * 2020-02-21 2023-05-08 エヌエフエス アイピー ホールディングス、エルエルシー 薬剤を有する電界紡糸構造体、並びにその製造方法及び使用
US20230136789A1 (en) 2020-03-05 2023-05-04 Foundry Therapeutics, Inc. Polymer implants
EP4142477A1 (en) 2020-05-01 2023-03-08 Pivot Bio, Inc. Stable liquid formulations for nitrogen-fixing microorganisms
EP4143293A1 (en) 2020-05-01 2023-03-08 Pivot Bio, Inc. Measurement of nitrogen fixation and incorporation
ES2876401B2 (es) 2020-05-11 2024-04-05 Bioinicia S L Parches auto-adhesivos de fibras para la liberación controlada de bioactivos
US20220175812A1 (en) 2020-12-03 2022-06-09 Battelle Memorial Institute Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery
AU2022253899A1 (en) 2021-04-07 2023-10-26 Battelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
EP4124336B1 (en) * 2021-07-30 2023-10-25 Cannamedical Pharma GmbH Transmucosal patch comprising a cannabinoid and/or an opioid
JP2024542227A (ja) 2021-11-23 2024-11-13 アフリックス デベロップメント アー／エス 粘膜パッチおよびその使用方法
CZ309661B6 (cs) * 2022-01-28 2023-06-21 Ing Medical S.R.O. Krycí prostředek s obsahem účinné látky
EP4661854A1 (en) * 2023-02-08 2025-12-17 Epitomee Medical Ltd. Methods for preparing an active layer and devices comprising same
WO2025051337A1 (en) 2023-09-06 2025-03-13 Afyx Development A/S Compositions and methods for treating and preventing oral cancer
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
WO2025110945A1 (en) * 2023-11-24 2025-05-30 Karadeni̇z Tekni̇k Uni̇versi̇tesi̇ Teknoloji̇ Transferi̇ Uygulama Ve Arasti̇rma Merkezi̇ Pharmaceutical formulations and production method used in pediatric anesthesia premedication
US12441996B2 (en) 2023-12-08 2025-10-14 Battelle Memorial Institute Use of DNA origami nanostructures for molecular information based data storage systems
WO2025206559A1 (ko) * 2024-03-28 2025-10-02 주식회사 아이메디텍 항균 및 지혈 기능의 의료용 나노섬유막 및 이를 포함하는 지혈제
CN118557798B (zh) * 2024-06-20 2024-11-26 苏州先觉新材料科技有限公司 一种水凝胶-静电纺丝膜双层混合支架及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61280423A (ja) 1985-06-05 1986-12-11 Kiyuukiyuu Yakuhin Kogyo Kk 口腔内粘膜貼付剤
DE4337152A1 (de) * 1993-10-30 1995-05-04 Merck Patent Gmbh Verfahren zur Herstellung von wäßrigen Chitosan-Lösungen und -Gelen
PL356924A1 (en) * 2000-01-28 2004-07-12 Smithkline Beecham Corporation Electrospun pharmaceutical compositions
CN1531418A (zh) * 2001-03-22 2004-09-22 ���ض������о�Ժ 制造可溶性剂型
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US7309498B2 (en) * 2001-10-10 2007-12-18 Belenkaya Bronislava G Biodegradable absorbents and methods of preparation
US20030017208A1 (en) * 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
KR100564366B1 (ko) * 2003-11-19 2006-04-07 재단법인서울대학교산학협력재단 나노 섬유형 부직포를 이용한 조직 재생용 차폐막 및 그의 제조 방법
JP4526851B2 (ja) * 2004-03-31 2010-08-18 明彦 谷岡 多糖類のナノスケールの繊維および成形体
EP1796822A4 (en) * 2004-10-06 2008-09-17 Res Foundation Suny INTENSE FLOW FILTRATION MEDIA WITH LOW ENCRYPTION
US7390760B1 (en) * 2004-11-02 2008-06-24 Kimberly-Clark Worldwide, Inc. Composite nanofiber materials and methods for making same
WO2006106514A2 (en) * 2005-04-06 2006-10-12 Nicast Ltd. Electrospun dosage form and method of producing the same
US9011754B2 (en) * 2006-12-05 2015-04-21 Nanyang Technological University Manufacturing three-dimensional scaffolds using electrospinning at low temperatures
WO2009031620A1 (ja) 2007-09-05 2009-03-12 Taiyokagaku Co., Ltd. 水溶性電界紡糸シート
US8361492B2 (en) * 2008-04-29 2013-01-29 Ocugenics, LLC Drug delivery system and methods of use
US8535727B2 (en) * 2009-02-25 2013-09-17 North Carolina State University Biodegradable non-woven fabric having plant virus encapsulated actives for drug delivery
US20110111012A1 (en) * 2009-11-12 2011-05-12 Hemcon Medical Technologies, Inc. Nanomaterial wound dressing assembly
RU2487701C2 (ru) * 2011-07-26 2013-07-20 Общество с ограниченной ответственностью "Инмед" Раствор для получения материала на основе хитозана, способ получения гемостатического материала из этого раствора (варианты) и медицинское изделие с использованием волокон на основе хитозана
US9393216B2 (en) * 2012-11-06 2016-07-19 University Of Washington Through Its Center For Commercialization Vaginal matrices: nanofibers for contraception and prevention of HIV infection
EP2813212A1 (en) * 2013-06-10 2014-12-17 Zentiva, a.s. Drug formulation using API in nanofibers
RU2019126497A (ru) * 2017-01-23 2021-02-24 Афикс Терапьютикс А/С Способ получения электроспряденных волокон с высоким содержанием биоадгезивнго вещества

Also Published As

Publication number Publication date
RU2016151163A3 (es) 2018-12-26
US20230210784A1 (en) 2023-07-06
KR102127344B1 (ko) 2020-06-29
JP6770157B2 (ja) 2020-10-14
CN107072937A (zh) 2017-08-18
RU2016151163A (ru) 2018-07-10
WO2015189212A1 (en) 2015-12-17
IL249036B (en) 2019-02-28
IL264413B (en) 2022-04-01
BR112016028961A8 (pt) 2021-06-29
RU2019121301A (ru) 2019-08-20
US20170119690A1 (en) 2017-05-04
EP3154513B1 (en) 2019-11-20
BR112016028961A2 (pt) 2017-08-22
JP2017517577A (ja) 2017-06-29
US20220105049A1 (en) 2022-04-07
KR102185355B1 (ko) 2020-12-02
BR112016028961B1 (pt) 2023-04-11
CA2950821C (en) 2024-02-06
KR20170016970A (ko) 2017-02-14
SG10201808743VA (en) 2018-11-29
US10052291B2 (en) 2018-08-21
AU2015273608A1 (en) 2017-01-19
NZ746573A (en) 2023-07-28
AU2015273608B2 (en) 2019-04-04
SG11201609881WA (en) 2016-12-29
EP3622947B8 (en) 2025-03-05
IL291842A (en) 2022-06-01
MY173739A (en) 2020-02-18
AU2019204518B2 (en) 2020-07-16
NZ727975A (en) 2019-01-25
EP3622947A1 (en) 2020-03-18
MX2016015688A (es) 2017-05-30
ES2763524T3 (es) 2020-05-29
JP2019218400A (ja) 2019-12-26
IL249036A0 (en) 2017-01-31
CA2950821A1 (en) 2015-12-17
US20180325834A1 (en) 2018-11-15
JP6591536B2 (ja) 2019-10-16
EP3622947B1 (en) 2025-01-22
KR20200078682A (ko) 2020-07-01
US20240058276A1 (en) 2024-02-22
RU2695217C2 (ru) 2019-07-22
AU2019204518A1 (en) 2019-07-18
AU2015273608C1 (en) 2019-08-15
DK3154513T3 (da) 2020-01-27
EP3154513A1 (en) 2017-04-19
IL264413A (en) 2019-02-28

Similar Documents

Publication Publication Date Title
MX2021001118A (es) Composiciones que comprenden fibras obtenidas electrohidrodinamicamente para la administracion de dosificaciones especificas de una sustancia activa a piel o mucosa.
MY167777A (en) A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
MX2017006653A (es) Metodos para modular los niveles de fármaco en plasma mediante el uso de eritrohidroxibupropión.
PH12015501957A1 (en) Pharmaceutical composition of s-ketamine hydrochloride
PH12015502013A1 (en) Pharmaceutical composition of s-ketamine hydrochloride
MX2018015985A (es) Composiciones, dispositivos y metodos para el tratamiento del trastorno relacionado con el consumo de alcohol.
IN2013MU03583A (es)
MX389178B (es) Formulacion de proporcion fija de insulina glargina/lixisenatida.
CY1124041T1 (el) Συνθεσεις που περιλαμβανουν κυκλοσπορινη
EA201992832A1 (ru) Подкожное введение adamts13
EP3334719A4 (en) SUBSTITUTED BENZIMIDAZOLE, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
EA201490862A1 (ru) Осмотически активная система вагинальной доставки
MX375186B (es) Composiciones de anfetamina transdérmica estable y métodos de fabricación.
UA116776C2 (uk) Лікарська форма для продовженого вивільнення діючих речовин
MX2015015537A (es) Formulacion de pastillas de nicotina.
MX386987B (es) Mini-tabletas de melatonina y métodos de fabricación de las mismas.
CL2017001680A1 (es) Composición farmacéutica para el tratamiento de enfermedades gastrointestinales
EA201891848A1 (ru) Фармацевтическая композиция для применения в лечении фиброза
TR201903234T4 (tr) Parkinson hastalığının tedavisinde kullanılmaya yönelik dopamin içeren farmasötik çözelti.
EA201691596A1 (ru) Составы гепарина для наружного применения
IN2015DE03084A (es)
MX359973B (es) Sistema farmacéutico para la administración oral de sustancias terapéuticas sensibles.
IN2013MU03544A (es)
GT201500116A (es) Mètodo para preparar derivados de feniloximetil-nitro-imidazol y su uso del mismo